Pharmaceuticals
Explore our Portfolio
- ACTEMRA
-
ACTEMRA
ACTEMRA (tocilizumab, known as RoACTEMRA within the EU) is the first interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody developed for the treatment of RA (rheumatoid arthritis) and is a novel approach to help tackle this debilitating disease. IL-6 has been identified as having a fundamental role in the inflammation process in RA.
For indication information see RoACTEMRA.
ACTEMRA is currently approved in Japan, the European Union (as RoACTEMRA), Switzerland, India, Moldova, Peru, Kuwait, Brazil and Liechtenstein and pending approvals in the US and other countries around the world.
more - Anaprox
- Avastin
-
Avastin
Indicated in combination with chemotherapy for the treatment of advanced colorectal, breast, and lung cancer and in combination with interferon alfa for advanced renal cell cancer. more
- Bactrim
- Bondronat
- Bonviva / Boniva
- CellCept
-
CellCept
Used in the prevention of organ rejection in patients receiving kidney, heart, or liver transplants. more
- Dilatrend
- Dormicum
-
Dormicum
For sedation in the premedication in advance of diagnostic or operative interventions. more
- Fuzeon
-
Fuzeon
Indicated in combination with other antiretroviral medicinal products for the treatment of HIVinfected patients who failed or could not tolerate previous treaments. more
- Herceptin
- Invirase
-
Invirase
Invirase is indicated for the treatment of HIV infected adult patients, in combination with ritonavir and other antiretroviral medicinal products. more
- Kytril (Kevatril)
-
Kytril (Kevatril)
Used in the prevention of nausea and vomiting associated with chemotherapy or radiation. more
- Lariam
-
Lariam
Used in the prevention and treatment of malaria. more
- Lucentis
-
Lucentis
Lucentis® (ranibizumab injection) is indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD). more
- MabThera
- MabThera in RA
-
MabThera in RA
Indicated for use in combination with methotrexate for reducing signs and symptoms in adult patients with moderately- to severely-active rheumatoid arthritis (RA). more
- Madopar
-
Madopar
Used in the treatment of patients with Parkinson?s disease and restless leg syndrome (RLS). more
- Mircera
-
Mircera
Used to treat patients with symptomatic anaemia associated with chronic kidney disease (CKD). more
- NeoRecormon
-
NeoRecormon
Used to treat patients with symptomatic anaemia associated with chronic kidney disease (CKD) and to treat chemotherapy-related anaemia in cancer patients. more
- Neupogen
- Pegasys
- Pulmozyme
- Roaccutane / Accutane
- RoACTEMRA
-
RoACTEMRA
RoACTEMRA (tocilizumab, known as ACTEMRA outside of the EU) is the first interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody developed for the treatment of RA (rheumatoid arthritis) and is a novel approach to help tackle this debilitating disease. IL-6 has been identified as having a fundamental role in the inflammation process in RA.
RoACTEMRA, in combination with methotrexate (MTX), is indicated for the treatment of adult patients with moderate to severe RA who have either responded inadequately to, or who were intolerant to, previous therapy with one or more disease modifying anti-rheumatic drugs (DMARDs) or tumour necrosis factor (TNF) antagonists. In these patients, RoACTEMRA can be given as monotherapy in cases of intolerance to methotrexate (MTX) or where continued treatment with MTX is inappropriate.
more - Rocaltrol
- Rocephin
- Roferon-A
-
Roferon-A
Used in the treatment of patients with chronic hepatitis C, hairy cell leukemia, and AIDS-related Kaposi's sarcoma. more
- Tamiflu
- Tarceva
-
Tarceva
For the treatment of patients with lung and pancreatic cancer. more
- Toradol
- Valcyte
-
Valcyte
Used for the prevention of cytomegalovirus (CMV) infections in kidney, heart, and pancreas transplant patients. Used in the treatment of CMV retinitis in patients with AIDS. more
- Valium
- Vesanoid
- Viracept
- Xeloda
- Xenical
- Zenapax